Clinical Notes

TMJ BOTOX​

​

COVID-19 SCREENING
----------------------------------

Patient was pre-screened per Company and OS protocol prior to appointment.

Patient was screening when they arrived to the practice. 

​COVID-19 Consent was completed in addition all OS paperwork . Patient signature was verified.

​Room was disinfected using Super Sani-Cloth Germicidal Disposable Wipe (EPA Reg # 9480-4 ) techniques per manufactures protocols, followed by Clorox® Clean-Up® Cleaner + Bleach (EPA Reg. No. 5813-21) Spray and room dry. Room was verified by the other assistant for completion via COVID-19 Room disinfection checklist.

​Patient also rinsed with 1.5% hydrogen peroxide for 30 second 

​
​​Progress Note
------------------
Patient seen and consulted on previous visit for TMJ Disorder

where Botox was recommended

​

Patient here today to get the Botox A treatment. All risk, benefit, complications discussed. Consent obtained 

​

​
ASSESSMENT / PLAN / RECOMMENDATION
---------------------------------------------------------------

BOTOX Injection - 200 Units Type A

​

Masseter    R :  35U    Masseter    L : 35U

Temporalis  R : 15U    Temporalis  R : 15U

​

Descending Trapezius

  Superior portion R :15U   L :15U

  Middle Portion    R :5U      L :5U

  Lower Portion     R :20U    L :20U

​

Transverse Trapezius

   Medial Portion   R: 10      L : 10U

​

​

Patient to Follow-up in 1 month

​

​

Joseph Krajekian DMD, MD, FAAOMS, DABOMS